Filing Details
- Accession Number:
- 0001209191-16-143441
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-09-30 20:56:52
- Reporting Period:
- 2016-09-28
- Filing Date:
- 2016-09-30
- Accepted Time:
- 2016-09-30 20:56:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 353569 | Quidel Corp | QDEL | In Vitro & In Vivo Diagnostic Substances (2835) | 942573850 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1406652 | C Douglas Bryant | 12544 High Bluff Drive, Suite 200 San Diego CA 92130 | President & Ceo | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2016-09-28 | 17,110 | $8.50 | 291,121 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-09-28 | 17,110 | $21.61 | 274,011 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-09-29 | 16,767 | $8.50 | 290,778 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-09-29 | 16,767 | $21.22 | 274,011 | No | 4 | S | Direct | |
| Common Stock | Acquisiton | 2016-09-30 | 35,291 | $8.50 | 309,302 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2016-09-30 | 35,291 | $22.08 | 274,011 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Commom Stock | Non-Qualified Stock Options | Disposition | 2016-09-28 | 17,110 | $0.00 | 17,110 | $8.50 |
| Common Stock | Non-Qualified Stock Option | Disposition | 2016-09-29 | 16,767 | $0.00 | 16,767 | $8.50 |
| Common Stock | Non-Qualified Stock Option | Disposition | 2016-09-30 | 35,291 | $0.00 | 35,291 | $8.50 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 185,270 | 2013-02-02 | 2019-04-10 | No | 4 | M | Direct |
| 168,503 | 2013-02-02 | 2019-04-10 | No | 4 | M | Direct |
| 133,212 | 2013-02-02 | 2019-04-10 | No | 4 | M | Direct |
Footnotes
- The weighted average sale price for these transactions was $21.61 per share, with a range of $21.34 to $22.15 per share. Upon request, the Reporting Person hereby understakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average sale price for these transactions was $21.22 per share, with a range of $20.89 to $21.91 per share. Upon request, the Reporting Person hereby understakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares sold at each separate price.
- The weighted average purchase price for these transactions was $22.08 per share, with a range of $22.00 to $22.20 per share. Upon request, the Reporting Person hereby undertakes to provide to staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder, the full information regarding the number of shares purchased at each separate price.
Billionaire Hedge Funds
